How to Optimize Female Hormone Health for Vitality & Longevity | Dr. Sara Gottfried

Gottfried recommends women get baseline panels in their 20s–30s: estrogen, progesterone, testosterone (timed ~day 19–22 of cycle), DHEA, cortisol (preferably salivary), and thyroid, plus metabolomics via dried urine when possible. Adding micronutrient testing (e.g., magnesium, B vitamins, glutathione) and stool testing for microbiome markers like beta‑glucuronidase helps identify early imbalances that will matter more in perimenopause and beyond.

Gottfried rejects the conventional definition of constipation (one BM every 3 days); functionally, she considers anything less than a complete bowel movement every morning as constipation. Women have ~10 feet longer gut, more tortuous colons, higher thyroid dysfunction, and far more constipation than men. Constipation often reflects broader dysregulation of the hypothalamic‑pituitary‑adrenal‑thyroid‑gonadal‑gut axis and should be addressed aggressively (fiber/vegetables, magnesium, microbiome support, stress/autonomic regulation).

Gottfried frames women’s health within the PINE system (psycho‑immuno‑neuro‑endocrine) and notes women’s higher prevalence of trauma, depression, autoimmune disease, thyroid issues, and insomnia. Chronic perceived stress and intergenerational trauma alter cortisol patterns (especially flattened or inverted rhythms), increasing risk for anxiety, depression, autoimmune disease, fibromyalgia, and worse cancer outcomes. She emphasizes treating perceived stress (breathwork, meditation, yoga, social connection, sex/orgasm) rather than just “reducing stressors.”

PCOS involves androgen excess (clinical or biochemical), ovulatory dysfunction, and sometimes cystic ovaries, but phenotypes vary. Insulin resistance/hyperinsulinemia can drive ovarian androgen overproduction, and Gottfried stresses that women with PCOS have substantially elevated long-term risk of diabetes, cardiovascular disease, and possibly later-life cognitive issues—not just irregular periods or infertility. Treating only for pregnancy (e.g., ovulation drugs) or masking with birth control ignores this cardiometabolic trajectory.

While the pill reduces ovarian cancer risk and offers reproductive autonomy, Gottfried calls synthetic oral contraceptive exposure an iatrogenic endocrinopathy. Documented effects include micronutrient depletion, microbiome changes, elevated inflammatory markers (hs‑CRP), altered HPA rigidity, thyroid disruption, elevated sex hormone-binding globulin (SHBG) with persistent suppression of free testosterone, and up to ~20% clitoral shrinkage. She strongly favors non-hormonal copper IUDs (and vasectomy) when possible, noting copper IUDs are as effective as tubal ligation and have the highest satisfaction rates yet are least used.